SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Cannavigia Announces Appointment of Timo Bongartz as New CEO

    By

    CANNAVIGIA, a leading Swiss tech start-up specializing in innovative cannabis solutions through software and consulting, has revealed a significant leadership change. Luc Richner, the company’s founder and current CEO will transition to the Chief Strategy Officer role, while Timo Bongartz, the incumbent Chief Commercial Officer (CCO), will step into the position of CEO. This strategic shift aims to drive CANNAVIGIA, ‘s growth and reinforce its dedication to client-centric excellence.

    During Luc Richner’s tenure as CEO, CANNAVIGIA, has witnessed remarkable growth and innovation in the global medical cannabis market. Together with co-founders Philipp Hagenbach and Elias Galantay, alongside a dedicated team, CANNAVIGIA, has achieved notable milestones including securing long-term contracts with the Federal Office of Public Health of Switzerland, expanding its clientele to over 100 globally, and garnering recognition as an award-winning start-up. The positive feedback from clients and employees regarding Timo Bongartz’s leadership has solidified confidence in his ability to assume this pivotal role.

    T. Bongartz (CEO), E. Galantay (Co-founder & Head of Innovation), P. Hagenbach (Co-founder & COO), L. Richner (Co-founder & CSO) Copyright: Vigia AG

    “Timo Bongartz is the ideal leader to steer CANNAVIGIA, towards its next phase of growth,” stated Luc Richner. “His profound industry expertise, coupled with a proven track record as a seasoned professional in roles like General Manager, Head of Smart Farming, Innovation Leader and Senior Consultant positions him well to assume this responsibility. His accomplishments, including substantial growth in software client base, securing strategic consulting projects and successfully launching CANNAVIGIA, Club for the German club market, exemplify his ability to advance our mission. I have great confidence in Timo’s capacity to consistently deliver exceptional value to our clients and all our stakeholders to advance our vision towards a fully transparent and compliant global cannabis industry.”

    Timo Bongartz, Chief Executive Officer at Cannavigia, Copyright: Timo Bongartz

    “I am privileged to embrace the CEO role at CANNAVIGIA,” expressed Timo Bongartz. “I extend my gratitude to the founders for their confidence in me. My drive is to elevate CANNAVIGIA to a higher level of maturity and scalability. I have confidence in our talented team and am enthusiastic about realizing our vision to digitize, streamline, and optimize the cannabis supply chain, catering to both patients and consumers in upcoming adult-use markets. With new developments in the pipeline, including a significant announcement in September, we are well-positioned to continue our journey of innovation and excellence in cannabis and new verticals.”

    Philipp Hagenbach remarked, “I am confident about the strategic direction we are embarking on and looking forward to this significant impact on the organization and industry as well as the future milestones we will achieve.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free